Medical Countermeasures W.H.O. Partner Program Allocates 238,000 Doses of Mpox Vaccine to Four CountriesGlobal Biodefense StaffMarch 19, 2025
Medical Countermeasures Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical CountermeasuresGlobal Biodefense StaffMarch 18, 2025
Medical Countermeasures Tecovirimat Shown to Lack Efficacy as Treatment for Clade II MpoxGlobal Biodefense StaffMarch 12, 2025
CRADA Opportunity: Developing Protein Nanoparticles for the Display of Viral Epitopes Contracts + Grants March 13, 2019 …
US Invests Additional 44 Million in Smallpox Vaccine Manufacturing Contracts + Grants January 22, 2019 …
New Vaccine Manufacturing Innovation Centre Bolsters UK Pandemic Preparedness Featured News January 22, 2019 …
BARDA Looks to Expand Clinical Studies Network for Biodefense Countermeasures Contracts + Grants January 14, 2019 …
Ridgeback Biotherapeutics Licenses mAb114 Ebola Treatment from NIAID Industry News December 13, 2018 …
Whooping Cough: Tulane Awarded $8.5M to Develop Next-Generation Pertussis Vaccine Contracts + Grants November 15, 2018 …
Two Vaccines Against H7N9 Influenza Viruses Show Safety and Immunogenicity in Ferrets Featured News November 11, 2018 …
Most Know Kids Can Die From Flu, Yet Many Still Haven’t Had Children Vaccinated Featured News November 8, 2018 …
Antibiotic Resistance Could Take Us Back To the ‘Dark Ages’ Antimicrobial Resistance November 6, 2018 …
Countermeasure Development: First Ever FDA Qualification of Clinical Safety Biomarker Featured News October 29, 2018 …
SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox Medical Countermeasures October 4, 2018 …
Soligenix’s Innate Defense Regulator Selected for NIH Commercialization Transition Funding Contracts + Grants September 20, 2018 …
